Molecular Subtypes and Risk Prediction Model Based on Malignant Cell Differentiation Trajectories in Breast Cancer
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Penghui Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Differentiation. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan Province (Youth Project).
Abstract (Originalsprache)
Breast cancer (BRCA) is characterised by complex cellular heterogeneity and differentiation hierarchies, which play a crucial role in bone metastasis and therapeutic resistance. However, existing classification systems remain inadequate in capturing these complexities, limiting their effectiveness in guiding treatment strategies. To address this gap, we integrated single‐cell RNA‐seq profiles, spatial transcriptomes, along with 1097 bulk RNA‐seq profiles of TCGA‐BRCA cohort to dissect the molecular landscape of BRCA. By performing UMAP analysis, we identified nine tumour clusters and three spatially distinct spot types (immune, stromal and malignant spots) and further delineated 11 differentiation states from 2493 malignant spots. Through clustering, monocle 2 pseudo‐time and prognostic analyses, we identified the prognostic BRCA cell fate‐related genes, then constructed a novel BRCA stratification system (four subtypes) with differential prognosis, biological plausibility and clinical significance. Also, least absolute shrinkage and selection operator (LASSO) regression analysis was performed for the BRCA cell fate‐related genes in constructing a prognostic model. The model has modest accuracy and accordance (AUC = 0.708), which could distinguish BRCA patients into high‐risk or low groups. With correlation analysis, regulation networks were constructed for different subtypes based on the key cell fate‐related genes, transcription factors, metastasis‐related pathways, immune components and so on, to investigate the regulatory relationships between primary BRCA and BRCA bone metastasis. Afterwards, we identified the most significant inhibitors (puromycin, MS‐275, megestrol, aesculetin) for bone metastatic BRCA, which might have potential translational significance. In all, we developed a novel molecular stratification system for BRCA based on the cell fate‐related markers of malignant cells, which offered strong translational potential for diagnosis, prognosis and personalised therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
- Research Unit of Key Techniques for Treatment of Burns and Combined Burns and Trauma Injury, Chinese Academy of Medical Sciences, Shanghai, China.
- Tongji University School of Medicine, Shanghai, China.
- Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Penghui Yan, Zongqiang Huang
Förderung
- Natural Science Foundation of Henan Province (Youth Project)
Zitieren
APA
Yan, P., Sun, H., Wang, S., Huang, R., Shi, C., Yang, Q., Qiao, Y., Wang, H., Kong, D., Zhu, J., Yang, Y., & Huang, Z. (2025). Molecular Subtypes and Risk Prediction Model Based on Malignant Cell Differentiation Trajectories in Breast Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70680
Vancouver
Yan P, Sun H, Wang S, Huang R, Shi C, Yang Q, et al. Molecular Subtypes and Risk Prediction Model Based on Malignant Cell Differentiation Trajectories in Breast Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70680
BibTeX
@article{Yan2025,
author = {Yan, Penghui and Sun, Hanlin and Wang, Siqiao and Huang, Runzhi and Shi, Chaofeng and Yang, Qihang and Qiao, Yibo and Wang, Haonan and Kong, Deqian and Zhu, Jiwen and Yang, Yunqing and Huang, Zongqiang},
title = {Molecular Subtypes and Risk Prediction Model Based on Malignant Cell Differentiation Trajectories in Breast Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70680}
}
EUVIMED